Pre-gestational stress reduces the ratio of 5-HIAA to 5-HT and the expression of 5-HT1A receptor and serotonin transporter in the brain of foetal rat by Huang, Yuejun et al.
RESEARCH ARTICLE Open Access
Pre-gestational stress reduces the ratio of
5-HIAA to 5-HT and the expression of 5-HT1A
receptor and serotonin transporter in the
brain of foetal rat
Yuejun Huang
1, Hongwu Xu
2, Hui Li
3, Hanhua Yang
1, Yunbin Chen
4* and Xuechuan Shi
1*
Abstract
Background: Many studies have found that stress before or during pregnancy is linked to an increased incidence
of behavioural disorders in offspring. However, few studies have investigated hypothalamic-pituitary-adrenal (HPA)
axis activity and the serotonergic system as a consequence of pregestational stress. In the present study, we
investigated the effect of pre-gestational stress on HPA axis activity in maternal rats and their foetuses and
examined whether changes in HPA axis activity of maternal rats produced functional changes in the serotonergic
system in the brain of foetuses.
Results: We used the behavioural tests to assess the model of chronic unpredictable stress (CUS) in maternal rats.
We found the activity in the open field and sucrose consumption was lower for rats with CUS than for the
controls. Body weight but not brain weight was higher for control foetuses than those from the CUS group. Serum
corticosterone and corticotrophin-releasing hormone levels were significantly higher for mothers with CUS before
pregnancy and their foetuses than for the controls. Levels of 5-hydroxytryptamine (5-HT) were higher in the
hippocampus and hypothalamus of foetuses in the CUS group than in the controls, and 5-hydroxyindoleacetic acid
(5-HIAA) levels were lower in the hippocampus in foetuses in the CUS group than in the control group. Levels of
5-HIAA in the hypothalamus did not differ between foetuses in the CUS group and in the control group. The ratio
of 5-HIAA to 5-HT was significantly lower for foetuses in the CUS group than in the control group. Levels of 5-
HT1A receptor were significantly lower in the foetal hippocampus in the CUS group than in the control group,
with no significant difference in the hypothalamus. The levels of serotonin transporter (SERT) were lower in both
the foetal hippocampus and foetal hypothalamus in the CUS group than in the control group.
Conclusions: Our data demonstrate that pre-gestational stress alters HPA axis activity in maternal rats and their
foetuses, which is associated with functional changes in 5-HT activity (5-HT, 5-HIAA and ratio of 5-HIAA to 5-HT), as
well as the levels of the 5-HT1A receptor and SERT in the hippocampus and hypothalamus of foetuses.
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Many studies in humans and animals have found that
emotional disturbance and distress before or during
pregnancy that results from natural or human-made dis-
asters, chronic interpersonal tension or adverse condi-
tions in the home or workplace are linked to an
increased incidence of behavioural disorders in offspring
[1-3]. These disorders include impaired memory and
language development, autism, attention deficits, schizo-
phrenia, anxiety disorder and depression.
Studies of the neurobiological mechanisms underlying
the interaction between maternal stress and adult men-
tal disorders suggest the involvement of multiple neuro-
transmitter systems [4,5]. Changes in activity of the
central serotonin [5-hydroxytryptamine (5-HT)] system
play a major role in many of these behavioural aberra-
tions [6,7]. During pregnancy, the 5-HT system has a
fundamental role in the development of the central ner-
vous system of the foetus, and 5-HT neurotransmission
is involved in the activation and feedback of the
hypothalamic-pituitary-adrenal (HPA) axis throughout
life [8,9]. Because serotonin levels within the synaptic
cleft are regulated by the activity of the serotonin trans-
porter (SERT) protein, SERT is critical for regulating
serotonergic function. Stressful experiences and changes
in the SERT gene or protein levels have been linked to
behavioural disorders [10-12]. For example, genetic var-
iants in the SERT gene have been associated with
increased anxiety [13,14], neuroticism and depressive
symptoms; SERT-knockout mice show altered levels of
5-HT1A receptors and a stress-mediated increase in
corticosterone (COR) and corticotrophin-releasing hor-
mone (CRH) [15]. Alterations in SERT function can
cause adaptive changes in 5-HT1A receptor levels
[16-18]. In addition, humans with depression and
decreased SERT levels showed changes in 5-HT1A
receptor density [19]; changes in 5-HT1A receptor func-
tion were noted in SERT-knockout mice [18]. However,
these studies have focused on the effects on offspring of
stress exposure during pregnancy. Only a few studies
have examined the effect of chronic unpredictable stress
(CUS) before pregnancy on neurobiological variables in
offspring [3].
To date, no studies have investigated HPA axis activity
or the serotonergic system in corresponding brain
regions of the foetus as a consequence of pre-gestational
stress. Therefore, the first goal of this study was to
investigate whether pre-gestational stress alters HPA
axis activity in maternal rats and their foetuses. Changes
in the HPA-axis activity of maternal rats may not neces-
sarily produce changes in the 5-HT system of the foetus,
so the second goal of this study was to examine whether
changes in the HPA axis activity of maternal rats
produced functional changes by measuring 5-HT activity
[5-HT, its metabolite 5-hydroxyindoleacetic acid (5-
HIAA) and the ratio of 5-HIAA to 5-HT], as well as 5-
HT1A receptor and SERT levels in corresponding brain
regions of the foetal brain. And the third goal of this
study was to investigate the mechanisms involved.
Methods
Animals
Adult male (n = 10) and female (n = 20) Sprague-Daw-
ley rats (approximately 8 weeks old; 250-300 g and 200-
250 g, respectively) were provided by the Animal Center
of Shantou University. Female rats were nulliparous.
Before the beginning of any stressful procedures, female
rats were divided into 2 groups for treatment: control (n
= 8) and chronic unpredictable stress (CUS) (n = 12).
Female rats were housed singly, and male rats were
housed in pairs in plastic, non-transparent cages (60 ×
40 × 25 cm) in separate rooms under controlled 12-h
light/12-h dark conditions (lights on at 08:00) and tem-
perature (24°C). All rats had free access to food and
water throughout the experiments, unless specified by
the experimental procedure.
Female rats exhibited a normal estrous cycle (4-5 days
of estrous) before the start of the experiment, with
equal distribution of different stages of the estrous cycle.
The estrous cycle was reconfirmed during the last week
of CUS with the use of vaginal smears [20].
All animal experiments were reviewed and approved
by the Medical Animals Care and Welfare Committee
of Shantou University Medical College (Shantou, China).
All studies were carried out in accordance with the US
National Institutes of Health Guide for the Care and
Use of Laboratory Animals (NIH Publications No. 80-23
revised 1996). Every effort was made to minimize the
number of animals used and reduce suffering.
CUS procedure
Body weight of females was measured before the start of
CUS (W0) and once a week (W1, W2, W3) during CUS.
The CUS procedure and sucrose intake test and open
field test were as we previously described [3]. The sche-
dule is in Table 1 and Table 2.
Pregnancy of female rats
When the CUS procedure was finished (24 h after the
last stressor), all female rats were housed in pairs with 1
male for 1 week for mating. The day when sperm was
observed in vaginal smears was designated as embryonic
day 0 (E0), and blood samples were taken from the vena
cava caudalis between 10:00 and 12:00. Nest material
was provided for gestational female rats, which were
housed singly and not disturbed.
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All control rats (n = 8) and 9 of 12 CUS rats became preg-
nant. All pregnant rats were still pregnant at embryonic
day 20 (E20). The pregnant rats were anaesthetised with
pentobarbital. The uteri of pregnant rats were exposed by
opening the peritoneal cavity after anaesthesia. Then the
foetuses were dislodged from the uterus and weighed.
There were 87 foetuses (47 females and 40 males) from
the pregnant rats of the control group and 92 foetuses (43
females and 49 males) from the CUS group. To assess
serum COR and CRH levels, blood samples were quickly
taken by removing the head of the foetus. Due to the low
volume of serum in foetuses, COR and CRH levels were
measured in pooled serum samples from foetuses from
the same pregnant rat. All blood samples were collected
between 10:00 and 12:00. The brains of foetuses were
rapidly removed and weighed. Each hypothalamus was dis-
sected on ice into two equal parts divided by the midline.
The left side of hippocampus and one of the equal part of
hypothalamus were homogenized and deproteinized in
500 μl of 0.2 N perchloric acid (Merck KgaA, Darmstadt,
Germany) solution containing 7.9 mM Na2S2O5 and 1.3
mM disodium ethylenediaminetetraacetic acid (Na
2EDTA) (both from Riedel-de Haën AG, Seelze, Ger-
many). The homogenate was centrifuged at 14,000 rpm
for 30 min in 4°C, and the supernatant was stored at - 80°
C. Analysis involved high-performance liquid chromato-
graphy (HPLC) as described [21] with some modification.
All samples were measured within 1 month after homoge-
nization; previous studies have shown that monoamines
remain stable up to 1 month after homogenization [22].
The right side of hippocampus and the other part of
hypothalamus were frozen in liquid nitrogen and stored at
-70°C for quantitative real-time reverse transcription poly-
merase chain reaction (RT-PCR) and western blot analysis.
Before RT-PCR and western blot analysis, the brain tissue
was pounded to pieces. Several of these pieces were used
for RT-PCR, and the others were used for western blot
analysis.
Measurement of COR and CRH levels
Blood samples were centrifuged at 4000 rpm for 30 min.
The serum was collected and frozen at -70°C until use.
Serum COR and CRH levels were determined with a stan-
dard radioimmunoassay kit (ICN Biomedicals, Costa
Mesa, CA, USA). The sensitivity of the COR radioimmu-
noassay kit was 25 pg/ml. The inter- and intra-assay coef-
ficients of variation were both 8%. The sensitivity of the
CRH radioimmunoassay kit was 40 pg/ml. The intra- and
inter-assay variability were 3.84% and 10.36%, respectively.
HPLC procedure
HPLC was used to assay 5-HT and 5-HIAA. The HPLC
procedure was performed according to the method
Table 2 The CUS procedure
Time Course of the experiment
The 1st day 9:00 cage rocking (5 times per second) for 15 min
The 2nd day 9:00 swimming in cold (4°C) water for 5 min
The 3rd day 9:00 soiled cage (250 ml of tap water into the sawdust
bedding) for 24 h
The 4th day 9:00 lights on overnight
The 5th day 9:00 cage tilting for 24 h
The 6th day 9:00 restraint for 12 h
The 7th day 8:00 food and water deprivation for 24 h
The 8th day 8:00 one-bottled-sucrose test sessions (last 1 h)
9:00 soiled cage for 24 h
The 9th day 9:00 electric stimulus (1.0 mA, each time for 1 second,
10 times per minute) for 5 min
The 10th day 9:00 elevated temperature (40°C) for 15 min
The 11th day 9:00 cage rocking for 15 min
The 12th day 9:00 lights on overnight
The 13th day 9:00 restraint for 12 h
The 14th day 8:00 food and water deprivation for 24 h
The 15th day 8:00 one-bottled-sucrose test sessions (last 1 h)
9:00 lights on overnight
The 16th day 9:00 swimming in cold water for 5 min
The 17th day 9:00 restraint for 12 h
The 18th day 9:00 electric stimulus for 5 min
The 19th day 9:00 cage rocking for 15 min
The 20th day 9:00 soiled cage for 24 h
The 21th day 9:00 cage tilting for 24 h (The CUS procedure finish)
The 22th day 6:30 weighed body weight and open field test
8:00 food and water deprivation for 24 h
The 23th day 8:00 one-bottled-sucrose test sessions (last 1 h)
Table 1 The adaptation period of sucrose intake test
Time Course of the experiment
The 1st day 8:00 food and water deprivation for 24 h
The 2nd day 8:00
an interval of 3 days
one-bottled-sucrose test sessions (last 1 h)
The 6th day 8:00 food and water deprivation for 24 h
The 7th day 8:00 one-bottled-sucrose test sessions (last 1 h)
an interval of 3 days
The 11th day 8:00 food and water deprivation for 24 h
The 12th day 8:00
an interval of 3 days
one-bottled-sucrose test sessions (last 1 h)
The 16th day 6:30 weighed body weight and open field test
8:00 food and water deprivation for 24 h
The 17th day 8:00 one-bottled-sucrose test sessions (last 1 h)
The 17th day 9:00 The beginning of CUS procedure
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monoamine analysis, an Agilent HC-C18 analytical col-
umn (250 mm × 4.6 mm, 5 μm; Agilent, USA) was
used. The mobile phase consisted of 20% methanol and
80% aqueous solution, which contained 30 mM citric
acid, 40 mM sodium acetate, 0.2 mM ethylenediamine-
tetraacetic acid (EDTA) disodium salt and 0.5 mM octa-
nesulfonic acid sodium salt, at a flow rate of 1.0 ml/min
and at pH value of 3.8. The level of 5-HT and 5-HIAA
were detected using a Waters 474 scanning fluorescence
detector (Waters, USA) with the excitation and emission
wavelengths set at 280 nm and 330 nm, respectively.
The HPLC system was connected to a computer to
quantify all compounds by comparing the area under
the peaks with the area of reference standards with spe-
cific HPLC software (Chromatography Station for Win-
dows). The turnover ratio of 5-HIAA to 5-HT is
considered an index of the activity of cells that cause
release of 5-HT, re-uptake and metabolism to 5-HIAA
[23].
Quantitative real-time RT-PCR
Brain tissues were stored at -70°C until the assay for 5-
HT1A mRNA level by quantitative real-time RT-PCR as
described [24]. Briefly, RNA was isolated from tissue by
the TRIzol method [25]. Samples were treated with
D N a s et or e m o v ec o n t a m i n a t i n gD N Ab e f o r ec D N A
synthesis by reverse transcription with the SuperScript
II system (Invitrogen). The oligonucleotide primers used
were for 5-HT1A (forward, 5’-CCAAAGAGCACC-
TTCCTCTG-3’,r e v e r s e ,5 ’-TACCACCACCATCAT-
CATCA-3’); GAPDH, as a housekeeping gene (forward,
5’-ACACTGTGCCCATCTACGAGG-3’, reverse, 5’-
AGGGGCCGGACTCGTCATACT-3’). PCR amplification
of cDNA involved the Quantitect SYBR Green PCR kit
(Qiagen). The products of PCR were monitored in real
time by the MyiQ Detection System (Bio-Rad), and gene
expression was determined by the 2T
-ΔΔC method [26].
Western blot analysis
Brain tissues were homogenized in cell lysis buffer for
western blot analysis (Beyotime, Jiangsu, China). Protein
(50 μg/lane) separated by SDS-PAGE was blotted onto
nitrocellulose (NC) membranes by electrophoretic trans-
fer. Blots were incubated in blocking buffer, which was
a mixture of 10% non-fat dry milk powder in tris buf-
fered saline containing 0.5% Tween-20 (TBS-T) for 1 h
at room temperature and washed three times for 10 min
each in TBS-T. Blots were then incubated at 4°C with
the primary antibodies mouse anti-b-actin or rabbit
anti-SERT (both 1:1000 dilution; Cell Signaling, USA),
and washed three times for 10 min each in TBS-T. Blots
were incubated with the appropriate horseradish peroxi-
dase-labelled secondary IgG antibody for 2 h at room
temperature, washed three times for 10 min each in
TBS-T, treated with BeyoECL reagents (Beyotime,
Jiangsu, China), and exposed to film (Kodak, USA).
Band intensity was quantified by use of Bandscan 5.0
(Glyko Bandscan software). The relative protein level of
SERT was calculated relative to that of b-actin.
Statistical analysis
Data are presented as mean ± S.D. The differences in
body weight and sucrose intake between the two mater-
nal groups in the same week were analysed using a t-
test, and the effect of CUS on body weight and sucrose
intake in maternal rats during the CUS procedure was
analysed by one-way repeated ANOVA. The data in the
open-field test were measured by t test. We performed
gender-specific comparisons of foetuses. Data for foe-
tuses were analyzed by t test. The correlations between
COR or CRH levels and the ratio of 5-HIAA to 5-HT
or 5-HT1A and SERT expression for foetuses were ana-
lyzed by Bivariate correlation analysis. Statistical signifi-
cance was set at P < 0.05.
Results
Effect of CUS on body weight and behaviour of maternal
rats
T a b l e3s h o w st h a tb o d yw e i g h ta n ds u c r o s ei n t a k eo f
the CUS group were lower than the body weight and
sucrose intake of the control group at week 2 and week
3. One-way repeated ANOVA with CUS as the indepen-
dent factor and time as the repeated factor revealed the
effect of CUS on body weight [F(1,18) = 12.379,P =
0.02] and sucrose intake [F(1,18) = 9.214, P = 0.043] in
maternal rats. The differences in relative sucrose intake
were similar to those for sucrose intake and not pre-
sented here. The moving behaviour of CUS maternal
r a t sw a ss i g n i f i c a n t l yl o w e ra tw e e k3t h a na tw e e k0
(see Table 4).
Body and brain weights of foetuses
Body weight, but not brain weight, was higher for con-
trol foetuses than the body weight from the CUS group
for both males and females (see Table 5).
Serum COR and CRH level in maternal rats and foetuses
Serum COR and CRH levels were significantly higher
for maternal rats with CUS before pregnancy than for
controls and were higher in foetuses in the CUS group
than in the control group for both males and females
(see Table 6).
The ratio of 5-HIAA to 5-HT in the hippocampus and
hypothalamus of foetuses
Table 7 shows levels of 5-HT higher in the hippocam-
pus and hypothalamus of foetuses in the CUS group
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lower in the hippocampus in foetuses in the CUS group
than in foetuses in the control group. Levels of 5-HIAA
in the hypothalamus did not differ between foetuses in
the CUS group and control group for both males and
females (see Table 7). The ratio of 5-HIAA to 5-HT was
significantly lower for both male and female foetuses in
the CUS group than in the control group for both brain
areas (see Table 7).
5-HT1A mRNA expression in the hippocampus and
hypothalamus of foetuses
Agarose gel electrophoresis revealed correctly sized 5-
HT1A and GAPDH amplicons (Figure 1). The relative
level of 5-HT1A to GAPDH was significantly lower in
the hippocampus for both male and female foetuses in
the CUS group than for foetuses in the controls, with
no significant difference in the hypothalamus between
foetal groups for either males or females (see Table 8).
SERT expression in the hippocampus and hypothalamus
of foetuses
Signals of b-actin and SERT could be detected in the
hippocampus and hypothalamus of foetuses (Figure 2).
The relative level of SERT to b-actin as shown was
lower in both the hippocampus and hypothalamus for
foetuses in the CUS group than in the controls for both
males and females (see Table 8).
Correlations
Significant positive correlations were observed in serum
COR as well as CRH levels between maternal rats and
their foetuses (r =0 . 6 7 4 ,p <0 . 0 1 ;r = 0.709, p <0 . 0 1 ,
respectively). High COR and CRH levels in foetuses
were correlated with low SERT expression in the hippo-
campus and hypothalamus (COR:r = -0.231, p < 0.05; r
= -0.304, p < 0.01, respectively) (CRH: r = -0.378, p <
0.01; r = -0.359, p <0 . 0 1 ,r e s p e c t i v e ly) and with ratios
of 5-HIAA to 5-HT (COR:r = -0.428 p <0 . 0 1 ;r =
-0.245, p < 0.05, respectively) (CRH:r = -0.491, p <0 . 0 1 ;
r = -0.263, p < 0.05, respectively). Low 5-HT1A expres-
sion in the hippocampus was highly correlated with a
low ratio of 5-HIAA to 5-HT (r = 0.721, p < 0.01) and
SERT expression (r = 0.683, p < 0.01).
Table 3 Body weight and sucrose intake of maternal rats during CUS
Target Groups n W0 W1 W2 W3
Body weight (g) Control 8 237.3 ± 3.9 245 ± 2.7 252.3 ± 5.3 258.6 ± 5.8
(234~240.5) (242.8~247.2) (247.9~256.6) (253.8~263.5)
CUS 12 237.6 ± 5.9 242.1 ± 7.4 245.8 ± 7** 249.5 ± 7.6**
(233.9~241.3) (237.4~246.8) (241.3~250.2) (244.7~254.3)
Sucrose intake (g) Control 8 10.09 ± 1.05 10.5 ± 0.85 11.33 ± 1.53 12.1 ± 1.36
(9.21~10.97) (9.79~11.21) (10.05~12.61) (10.96~13.23)
CUS 12 10.16 ± 0.97 10.4 ± 1.28 10.67 ± 1.66* 10.85 ± 1.8**
(9.54~10.78) (9.59~11.21) (9.61~11.73) (9.71~11.99)
Data are mean ± S.D. from week 0 to week 3. Data in bracket are 95% confidence intervals for each relevant statistic. *, **:P < 0.05, P < 0.01 compared with
control by the same week
Table 4 Moving behaviour of maternal rats in open field
test
Groups n Time Total path
(cm)
Central path
(cm)
Peripheral path
(cm)
Control 8 W0 2925.4 ± 254.1 293.3 ± 84.3 2632.1 ± 182.
(2713.0~3137.8) (222.8~363.8) (222.6~336.6)
W3 2861.1 ± 283.8 279.6 ± 68.2 2581.5 ± 233.2
(2623.9~3098.3) (2479.3~2784.9) (2386.6~2776.4)
CUS 12 W0 2904 ± 199.2 260.4 ± 45.0 2643.6 ± 210.7
(2777.4~3030.6) (231.8~289.0) (2509.8~2777.4)
W3 1489.3 ±
302.8**
107.5 ± 49.9** 1381.8 ± 483.4**
(1296.9~1681.7) (75.7~139.1) (1074.8~1688.8)
Data are mean ± S.D. before (W0) and after (W3) CUS procedure. Data in
bracket are 95% confidence intervals for each relevant statistic. **:P < 0.01
compared with week 0 by the same group
Table 5 Body weight and brain weight of foetuses
Groups n Body weight (g) Brain weight (mg)
Female foetuses of control 47 3.52 ± 0.10 166.3 ± 3.6
(3.49~3.55) (165.2~167.4)
Female foetuses of CUS 43 3.48 ± 0.16* 165.6 ± 3.0
(3.43~3.53) (164.7~166.5)
Male foetuses of control 40 3.67 ± 0.13 172.5 ± 2.6
(3.63~3.71) (171.7~173.3)
Male foetuses of CUS 49 3.61 ± 0.08* 170.6 ± 2.2
(3.59~3.63) (170.0~171.2)
Data are mean ± S.D. Data in bracket are 95% confidence intervals for each
relevant statistic. *: P < 0.05, compared with control by the same sex
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We aimed to elucidate whether pre-gestational stress in
maternal rats affects HPA axis activity and the seroto-
nergic system in the brains of their foetuses. We exam-
ined 5-HT activity (5-HT, 5-HIAA and the ratio of 5-
HIAA to 5-HT) and 5-HT1A receptor and SERT levels
in brain regions of foetuses. The ratio of 5-HIAA to 5-
HT and the level of SERT were significantly lower for
foetuses in the CUS group than in the control group.
Levels of 5-HT1A receptor were significantly lower in
foetal hippocampuses in the CUS group than in the
controls, with no significant difference in the hypothala-
mus. Finally, the level of SERT was lower in both the
hippocampus and hypothalamus of foetuses in the CUS
group than in the control group. The HPA axis and ser-
otonergic system may be dysregulated in the foetuses of
mothers exposed to CUS before pregnancy. From the
results of this study, we extended our knowledge of pre-
gestational stress-induced changes across several regions
of the foetal brain and provided several novel findings
about how pre-gestational stress can affect serotonergic
systems in foetal rats with stressed mothers.
We successfully established a model of CUS in mater-
nal rats. Body weight and behaviour findings for mater-
nal rats generally agreed with our previous findings [3],
so the CUS model was appropriate for our study.
Along with the reduced body weight of maternal rats
with CUS, the reduced body weight of their foetuses
suggests that growth retardation may relate to their
mothers with CUS before pregnancy. However, brain
weight did not differ between foetuses in the CUS group
and control group. Therefore, the growth retardation of
foetuses in the CUS group cannot explain all of our
findings, which appears to relate to an imbalanced
neuro-endocrine network after CUS in maternal rats
and their foetuses.
The serum COR and CRH levels were higher in
maternal rats with CUS before pregnancy than in con-
trol maternal rats. This finding may relate to the dysre-
gulation of the HPA axis after exposure to chronic
stress. This view is supported by previous studies
[27,28]. We found that pre-gestational CUS in mothers
Table 6 Serum COR and CRH levels of maternal rats and
foetuses
Groups n COR (ng/ml) CRH (pg/ml)
Maternal rats of control 8 139.5 ± 11.9 2.69 ± 0.19
(129.5~149.5) (2.53~2.85)
Maternal rats of CUS 12 202.5 ± 12.2** 3.63 ± 0.26**
(194.7~210.3) (3.46~3.80)
Female foetuses of control 47 174.2 ± 17.8 2.95 ± 0.51
(169.0~179.4) (2.80~3.10)
Female foetuses of CUS 43 220.3 ± 15.6** 3.76 ± 0.42**
(215.5~225.1) (3.63~3.89)
Male foetuses of control 40 158.8 ± 14.4 2.69 ± 0.40
(154.2~163.4) (2.56~2.82)
Male foetuses of CUS 49 191 ± 13.8** 3.6 ± 0.41**
(187.0~195.0) (3.48~3.72)
Data are mean ± S.D. Data in bracket are 95% confidence intervals for each
relevant statistic. **: P < 0.01 compared with control and the data of foetuses
compared with control by the same sex
Table 7 HPLC analysis results of 5-HT,5-HIAA and 5-HIAA/5-HT in the hippocampus and hypothalamus of foetuses
Groups n Position 5-HT (ng/g) 5-HIAA (ng/g) 5-HIAA/5-HT
Female foetuses of control 47 Hippocampus 215.4 ± 15.8 165.1 ± 9.6 0.771 ± 0.041
(210.8~220.0) (162.3~167.9) (0.759~0.783)
Hypothalamus 116.9 ± 8.2 44.5 ± 5.5 0.382 ± 0.021
(114.5~119.3) (42.9~46.1) (0.376~0.388)
Female foetuses of CUS 43 Hippocampus 236.3 ± 16.1** 135.8 ± 15.7** 0.572 ± 0.059**
(231.3~241.3) (130.9~140.7) (0.554~0.590)
Hypothalamus 146.7 ± 13.8** 46.1 ± 3.3 0.313 ± 0.052**
(142.5~150.9) (45.1~47.2) (0.297~0.329)
Male foetuses of control 40 Hippocampus 206.7 ± 16.4 173.2 ± 12.8 0.84 ± 0.069
(201.4~212.0) (169.1~177.3) (0.818~0.862)
Hypothalamus 141.6 ± 15.2 54.9 ± 3.8 0.391 ± 0.044
(136.7~146.5) (53.7~56.1) (0.377~0.405)
Male foetuses of CUS 49 Hippocampus 238.5 ± 10.5** 149.3 ± 10.2** 0.633 ± 0.07**
(235.5~241.5) (146.4~152.2) (0.613~0.653)
Hypothalamus 175.3 ± 13.3** 53.2 ± 6.3 0.312 ± 0.042**
(171.5~179.1) (51.4~55.0) (0.300~0.324)
Data are mean ± S.D. Data in bracket are 95% confidence intervals for each relevant statistic. **: P < 0.01 compared with control by the same sex and the same
position
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Page 6 of 11significantly increased COR and CRH levels in foetuses
in the CUS group as compared with controls for both
males and females, and significant positive correlations
in serum COR as well as CRH levels were observed
between maternal rats and their foetuses in our study.
Therefore, chronic stress can not only lead to an imbal-
ance in the neuro-endocrine network of maternal rats,
but it can also affect the HPA axis of the foetus via the
maternal-placental-foetal interface [29]. Several studies
have provided evidence that maternal stress causes ele-
vated levels of circulating COR in the foetus [30]. The
increase in the serum COR level of foetus results from
reduced maternal COR-binding globulin and impaired
regulation of the maternal HPA axis [31]. The HPA
axis, impaired in maternal rats with CUS, may release
stress hormones such as COR and CRH to enter the cir-
culation of foetus directly through the placental barrier.
On the other hand, the elevated level of circulating
COR in maternal rats reduces the blood flow of the
placenta, which decreases the supply of oxygen and
nutrients to the foetus and results in a high level of
COR in the foetus [29].
Early pregnancy is the most sensitive period in which
stress is associated with neuro-behavioural changes in
offspring [2]. Imposing CUS on maternal rats for a short
time before pregnancy may also affect offspring in the
early embryonic environment and thus have a profound
influence on the brain development of offspring [3].
During the foetal lifespan, the brain undergoes rapid
growth that is characterised by a high turnover of neu-
ronal connections. Therefore, the foetal brain is espe-
cially vulnerable to hormones that may reach it in
excess amounts from the maternal circulation as a result
of stress [32]. Peptides such as CRH and beta-endorphin
and COR may impede the formation of correct neural
connections and reduce plasticity in the developing foe-
tal brain [33]. Stress-induced levels of COR activate glu-
cocorticoid receptors that are present in the rat
Figure 1 RT-PCR analysis of 5-HT1A mRNA levels in the hippocampus and hypothalamus of foetuses. Lanes 1,2: CUS females and males
respectively; Lanes 3,4: control females and males, respectively; GADPH was a loading control.
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Page 7 of 11hippocampus, hypothalamus, pituitary, cingulate cortex
and amygdala from day 13 of gestation [34]. The ability
of the foetal HPA axis to respond to maternal stress was
shown by increased expression of CRH mRNA in the
foetal para-ventricular nucleus (PVN) on day 15 of
gestation in rats [35]. The abnormal HPA axis of the
foetuses results in high levels of COR and CRH. High
CRH levels affect g-aminobutyric acid (GABA) levels
and glutamate (Glu) neurons [36], thus leading to dis-
turbed inhibitory amino acids (GABA) and excitatory
amino acids (Glu), which may influence release of neu-
rotransmitters such as 5-HT and down-regulate the sen-
sitivity of 5-HT1A autoreceptors [37].
In this study, we showed that pre-gestational CUS
induced decreased serotonergic activity in foetuses with
decreased serotonergic ratios (5-HIAA to 5-HT) in the
hippocampus and hypothalamus and decreased 5-HIAA
levels in the hippocampus. Compared with control foe-
tuses, both male and female foetuses in the CUS group
showed increased 5-HT levels in the hippocampus and
hypothalamus. Surprisingly, 5-HIAA levels were lower in
the hippocampuses of foetuses in the CUS group than in
control group, with no significant difference in levels in
the hypothalamus of foetuses in the CUS group and con-
trols for both males and females. Serotonergic ratio and
serum COR and CRH levels in foetuses were significantly
correlated. Decreased serotonergic status in the hippocam-
pus and hypothalamus in foetuses in the CUS groups is
probably directly or indirectly associated with changes in
the HPA axis. By activating 5-HT1A receptors in the hip-
pocampus, 5-HT causes hyper-polarisation [38], the sup-
pression of hippocampal output and the subsequent
disinhibition of HPA axis [39,40]. However, decreased ser-
otonergic activity in foetuses in the CUS group could have
resulted from changes in serotonergic function mediated
by altered COR [41-43] and CRH [44,45] availability.
The 5-HT1A receptor is a crucial pre-synaptic autore-
ceptor in regulating the activity of 5-HT neurons and a
Table 8 Results of 5-HT1A mRNA and SERT levels in the hippocampus and hypothalamus of foetuses
Groups n Position 5-HT1A mRNA(× 10
-2) SERT
Female foetuses of control 47 Hippocampus 0.284 ± 0.051 0.312 ± 0.069
(0.269~0.299) (0.292~0.332)
Hypothalamus 0.272 ± 0.031 0.342 ± 0.059
(0.263~0.281) (0.325~0.359)
Female foetuses of CUS 43 Hippocampus 0.223 ± 0.036** 0.213 ± 0.06**
(0.212~0.234) (0.194~0.232)
Hypothalamus 0.266 ± 0.059 0.246 ± 0.037**
(0.248~0.284) (0.234~0.258)
Male foetuses of control 40 Hippocampus 0.288 ± 0.051 0.334 ± 0.042
(0.272~0.304) (0.320~0.348)
Hypothalamus 0.265 ± 0.044 0.351 ± 0.046
(0.251~0.279) (0.336~0.366)
Male foetuses of CUS 49 Hippocampus 0.233 ± 0.042** 0.226 ± 0.034**
(0.221~0.245) (0.216~0.236)
Hypothalamus 0.275 ± 0.028 0.235 ± 0.055**
(0.267~0.283) (0.219~0.251)
Data are mean ± S.D. Data in bracket are 95% confidence intervals for each relevant statistic. 5-HT1A mRNA levels are the relative level of 5-HT1A to GAPDH.
SERT levels are the relative level of SERT to b-actin. **: P < 0.01 compared with control by the same sex and the same position
Figure 2 Western blot analysis of relative SERT protein levels in the hippocampus and hypothalamus of foetuses. Lanes 1,2: CUS
females and males, respectively; Lanes 3,4: control females and males, respectively.
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hypothalamus and other parts of the brain [46]. There-
fore, the regulation of 5-HT1A receptor can have an
important role in psychological diseases. The hippocam-
pus is a major limbic target of the brainstem serotoner-
gic neurons that modulate emotion, cognitive and
behaviour through post-synaptic 5-HT1A receptors [47].
Serotonergic neurons in the raphe nucleus are among
the earliest to appear in the developing central nervous
system. The hippocampus accepts the neurotransmission
of 5-HT neurons from the dorsal raphe nucleus and
median raphe nucleus [48]. The hippocampus also con-
tains high levels of COR receptors in central brain areas.
It is extremely vulnerable to excessive COR [49], which
results in injury and may lead to decreased 5-HT1A
receptor expression. Thus, pre-gestational stress may
cause abnormal development of the serotonergic neu-
rons in the hippocampus of foetuses by changing levels
of stress hormones such as COR and CRH. We found
lower 5-HT1A mRNA expression in the hippocampus
of foetuses in the CUS group than in the control group
and significant correlations between 5-HT1A and serum
COR as well as CRH levels, which can support the
above view. It appears that hippocampal serotonin is cri-
tical for programming of HPA function; however, it is
possible that ascending fibres innervating the hypothala-
mus also play a role in this process. Many hypothalamic
functions are regulated by the serotonergic system,
which modulate the function of hypothalamus through
dendrites of the 5-HT1A autoreceptor in cell bodies and
the 5-HT1B autoreceptor at the nerve ends [50]. We
found no difference between male or female foetuses in
the CUS group and control group in level of 5-HT1A
receptor in the hypothalamus, which suggests that the
effect of pre-gestational stress on the hypothalamus
might have a closer relationship with the 5-HT1B auto-
receptor at the nerve ends.
We found a lower ratio of 5-HIAA to 5-HT and 5-
HT1A mRNA expression in the hippocampus of both
male and female foetuses in the CUS group than in the
control group and lower levels of SERT in both the hip-
pocampus and hypothalamus of foetuses in the CUS
group, which suggests a possible link between the three
factors. SERT is present throughout foetal development
and is expressed at high levels at the time of neurogen-
esis and rapid brain growth. Serotonin levels within the
synaptic cleft are regulated by the activity of the SERT
protein, which actively re-uptakes serotonin into the
pre-synaptic terminal and therefore regulates the dura-
tion of serotonin activity on its own autoreceptors [51].
In foetal rats, the main bilateral bundles of the ascend-
ing serotonergic axons pass through the mesencephalon,
and a ventral branch leaves the medial forebrain bundle
in the diencephalon to innervate the hypothalamus [52].
This pathway forms the direct synaptic connections
between serotonergic neuronsa n dt h eC R H - c o n t a i n i n g
cells of the hypothalamic PVN [35]. In this connection,
serotonin can activate HPA function through its excita-
tory effects on the PVN in adult animals, and the same
likely occurs in the peri-natal period [53]. Our findings
of the significant correlations between the SERT level
and CRH levels in foetuses may support this view. In
foetuses of the CUS group, which SERT was down-regu-
lated in the hippocampus and hypothalamus, the seroto-
nergic ratio (5-HIAA/5-HT) was also down-regulated in
the same region. Indeed, SERT gene promoter variations
conferred a blunted COR response in rhesus monkeys
exposed to pre-natal stress [54]. Therefore, COR-
mediated changes in SERT expression would likely have
a significant impact on the metabolism of serotonin in
the developing brain.
In our experiment, the impaired HPA axis of the foe-
tuses of maternal rats exposed to CUS before pregnancy
results in high levels of COR and CRH. High COR and
CRH levels can alter serotonin-mediated neurotransmis-
sion and may directly affect serotonin levels pre-synapti-
cally, in the synaptic cleft and post-synaptically [36,37].
Late pregnancy is known to be an important period for
synaptic formation of serotonergic neurons in rats [55].
Pre-natal exposure to dexamethasone during late preg-
nancy in rats decreases serotonin turnover in the cere-
bral cortex, hypothalamus and hippocampus [56].
Exposure to COR during pregnancy leads to develop-
mental changes in central serotonergic systems, as well
as other brain monoaminergic systems, including the
noradrenergic and dopaminergic pathways [57]. As sero-
tonergic functions can be modified by COR and CRH,
programmed changes in HPA function that are indepen-
dent of serotonin will have a permanent effect on the
serotonergic system. However, the relationship between
dopamine (DA) or norepinephrine (NE) and 5-HT sys-
tems in the regulation of HPA axis activity are complex
and not fully understood, and this requires further eluci-
dation in our future experimental studies.
Conclusions
In summary, three aspects of association likely exist
between the 5-HT system and HPA-axis function in the
foetuses of maternal rats with CUS before pregnancy:
(1) Changes in serum COR and CRH levels during criti-
cal windows of development will lead to modifications
in 5-HT activity (5-HT, 5-HIAA and ratio of 5-HIAA to
5-HT) and 5-HT1A receptor and SERT levels in the
hippocampus and/or hypothalamus of foetuses. (2) Since
serotonin is intimately involved in the tonic regulation
of the CRH neuron, permanent developmental modifica-
tion of the ascending serotonin system will lead to long-
term changes in HPA function. (3) As serotonergic
Huang et al. BMC Neuroscience 2012, 13:22
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Page 9 of 11function can be modified by COR and CRH, pro-
grammed changes in HPA function that are independent
of serotonin will have a permanent effect on the seroto-
nergic system. Although pre-natal brain development is
based on a genetic blueprint, pre-gestational stress can
also have a profound influence. However, many ques-
tions still need to be answered, including those pertain-
ing to the effects pre-gestational stress on the foetuses
in the role of the 5-HT system in the regulation of HPA
axis activity relate to other neurotransmitters such as
DA and NE, sex differences on the response of HPA
axis to stressful conditions, the specific signal transduc-
tion pathways and the effects of medical intervention.
We will address these questions in our forthcoming
studies.
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